Caleco Pharma Corp. (CAEH.OB) Moves Forward with Hepatitis Formulation
Caleco Pharma Corp., focused on the research and development of over-the-counter and prescription biopharmaceutical and consumer health products, has announced developments regarding its products targeting the global hepatitis C prescription market and the liver health maintenance market via a nutritional supplement formulation. Caleco identifies and develops products derived from natural sources, including plant extracts, functional oils, and probiotics. In particular, the company is targeting the $4 billion global hepatitis C prescription market, a market expected to double in size over the next seven years, reaching $8.5 billion by 2016. There are currently over 200 million people infected with chronic hepatitis…